Modeling altered T-cell development of SCID and OS patients with dermal fibroblast-derived iPSCs.

Modeling altered T-cell development of SCID and OS patients with dermal fibroblast-derived iPSCs.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal